JNCI Journal of the National Cancer Institute

MEMO TO THE MEDIA

Linda Wang and Katherine Arnold

Press Release: Studies of Prophylactic Surgery May Overestimate Risk Reductions
J. Natl. Cancer Inst. 2003 95: 925; doi:10.1093/jnci/95.13.925 [Extract] [Full Text]  

Linda Wang and Katherine Arnold

Press Release: Chemotherapy May Suppress Breast Cancer Risk in Hodgkin’s Survivors
J. Natl. Cancer Inst. 2003 95: 925; doi:10.1093/jnci/95.13.925-a [Extract] [Full Text]  

EDITORIALS

Frederic J. Kaye and Takefumi Komiya

New Leads Suggest a Clinically Relevant Genotype–Phenotype Relationship for the p53 Gene
J. Natl. Cancer Inst. 2003 95: 926; doi:10.1093/jnci/95.13.926 [Extract] [Full Text] [PDF]  

Dan L. Longo

Radiation Therapy in the Treatment of Hodgkin’s Disease—Do You See What I See?
J. Natl. Cancer Inst. 2003 95: 928; doi:10.1093/jnci/95.13.928 [Extract] [Full Text] [PDF]  

Peter C. Albertsen

The Prostate Cancer Conundrum
J. Natl. Cancer Inst. 2003 95: 930; doi:10.1093/jnci/95.13.930 [Extract] [Full Text] [PDF]  

NEWS

Damaris Christensen

Data Still Cloudy on Association Between Sunscreen Use and Melanoma Risk
J. Natl. Cancer Inst. 2003 95: 932; doi:10.1093/jnci/95.13.932 [Extract] [Full Text]  

Stat Bite: Incidence of and Mortality From Melanoma of the Skin, 1975–2000
J. Natl. Cancer Inst. 2003 95: 933; doi:10.1093/jnci/95.13.933 [Extract] [Full Text]  

James Schultz

Food Fight: NCI Aims for Consumer Clarity With Complaint Against Dairy Group
J. Natl. Cancer Inst. 2003 95: 934; doi:10.1093/jnci/95.13.934 [Extract] [Full Text]  

Renee Twombly

Framework Convention on Tobacco Control Signed; Countries Consider Plan’s Implementation
J. Natl. Cancer Inst. 2003 95: 935; doi:10.1093/jnci/95.13.935 [Extract] [Full Text]  

Christine Theisen

Statistical Projections, Modeling Techniques Help Researchers Measure Progress, Effectiveness
J. Natl. Cancer Inst. 2003 95: 937; doi:10.1093/jnci/95.13.937 [Extract] [Full Text]  

John Illman

U.K. Government Responds to Criticism of Medical Research Council
J. Natl. Cancer Inst. 2003 95: 938; doi:10.1093/jnci/95.13.938 [Extract] [Full Text]  

In Brief
J. Natl. Cancer Inst. 2003 95: 939; doi:10.1093/jnci/95.13.939 [Extract] [Full Text]  

Awards, Appointments, Announcements
J. Natl. Cancer Inst. 2003 95: 940; doi:10.1093/jnci/95.13.940 [Extract] [Full Text]  

Related Links on Cancer Statistics:
J. Natl. Cancer Inst. 2003 95: 937; doi:10.1093/jnci/95.13.937-a [Extract] [Full Text]  

COMMENTARY

Hester M. Klaren, Laura J. van’t Veer, Flora E. van Leeuwen, and Matti A. Rookus

Potential for Bias in Studies on Efficacy of Prophylactic Surgery for BRCA1 and BRCA2 Mutation
J. Natl. Cancer Inst. 2003 95: 941; doi:10.1093/jnci/95.13.941 [Extract] [Full Text] [PDF]  

REVIEW

Harvey A. Risch

Etiology of Pancreatic Cancer, With a Hypothesis Concerning the Role of N-Nitroso Compounds and Excess Gastric Acidity
J. Natl. Cancer Inst. 2003 95: 948; doi:10.1093/jnci/95.13.948 [Abstract] [Full Text] [PDF]  

ARTICLES

Steven A. Ahrendt, Yingchuan Hu, Martin Buta, Michael P. McDermott, Nicole Benoit, Stephen C. Yang, Li Wu, and David Sidransky

p53 Mutations and Survival in Stage I Non-Small-Cell Lung Cancer: Results of a Prospective Study
J. Natl. Cancer Inst. 2003 95: 961; doi:10.1093/jnci/95.13.961 [Abstract] [Full Text] [PDF]  

Flora E. van Leeuwen, Willem J. Klokman, Marilyn Stovall, Ellen C. Dahler, Mars B. van’t Veer, Evert M. Noordijk, Mariad A. Crommelin, Berthe M. P. Aleman, Annegien Broeks, Mary Gospodarowicz, Lois B. Travis, and Nicola S. Russell

Roles of Radiation Dose, Chemotherapy, and Hormonal Factors in Breast Cancer Following Hodgkin’s Disease
J. Natl. Cancer Inst. 2003 95: 971; doi:10.1093/jnci/95.13.971 [Abstract] [Full Text] [PDF]  

Matthew R. Cooperberg, Gary D. Grossfeld, Deborah P. Lubeck, and Peter R. Carroll

National Practice Patterns and Time Trends in Androgen Ablation for Localized Prostate Cancer
J. Natl. Cancer Inst. 2003 95: 981; doi:10.1093/jnci/95.13.981 [Abstract] [Full Text] [PDF]  

Samuel R. Denmeade, Carsten M. Jakobsen, Samuel Janssen, Saeed R. Khan, Elizabeth S. Garrett, Hans Lilja, S. Brogger Christensen, and John T. Isaacs

Prostate-Specific Antigen-Activated Thapsigargin Prodrug as Targeted Therapy for Prostate Cancer
J. Natl. Cancer Inst. 2003 95: 990; doi:10.1093/jnci/95.13.990 [Abstract] [Full Text] [PDF]  

BRIEF COMMUNICATIONS

Jane MacKenzie, Katherine S. Wilson, Jacqueline Perry, Alice Gallagher, and Ruth F. Jarrett

Association Between Simian Virus 40 DNA and Lymphoma in the United Kingdom
J. Natl. Cancer Inst. 2003 95: 1001; doi:10.1093/jnci/95.13.1001 [Abstract] [Full Text] [PDF]  

Michael F. Leitzmann, Meir J. Stampfer, Kana Wu, Graham A. Colditz, Walter C. Willett, and Edward L. Giovannucci

Zinc Supplement Use and Risk of Prostate Cancer
J. Natl. Cancer Inst. 2003 95: 1004; doi:10.1093/jnci/95.13.1004 [Abstract] [Full Text] [PDF]  

CORRESPONDENCE

Joanna H. M. Tong, Kwok Wai Lo, Florence W. L. Au, Dolly P. Huang, and Ka-Fai To

Re: Discrete Alterations in the BZLF1 Promoter in Tumor and Non-Tumor-Associated Epstein–Barr Virus
J. Natl. Cancer Inst. 2003 95: 1008; doi:10.1093/jnci/95.13.1008 [Extract] [Full Text] [PDF]  

Marina I. Gutiérrez, Stephen E. Straus, Muna M. Ibrahim, Janet K. Dale, and Kishor Bhatia

RESPONSE: Re: Discrete Alterations in the BZLF1 Promoter in Tumor and Non-Tumor-Associated Epstein–Barr Virus
J. Natl. Cancer Inst. 2003 95: 1009; doi:10.1093/jnci/95.13.1009 [Extract] [Full Text] [PDF]  

John L. Hopper and John A. Baron

Re: Oral Contraceptives and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
J. Natl. Cancer Inst. 2003 95: 1010; doi:10.1093/jnci/95.13.1010 [Extract] [Full Text] [PDF]  

Geertruida H. de Bock, Rob A. E. M. Tollenaar, Hadewych Papelard, Theodora P. M. Vliet Vlieland, Peter Devilee, Cornelis J. Cornelisse, and Jan P. Vandenbroucke

Re: Oral Contraceptives and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
J. Natl. Cancer Inst. 2003 95: 1011; doi:10.1093/jnci/95.13.1011 [Extract] [Full Text] [PDF]  

Matti A. Rookus, Richard Brohet, and Flora E. van Leeuwen

Re: Oral Contraceptives and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
J. Natl. Cancer Inst. 2003 95: 1012; doi:10.1093/jnci/95.13.1012 [Extract] [Full Text] [PDF]  

Gad Singer, Peter Schraml, Christopher Belgard, Anna Raggi, Stephan Dirnhofer, Philip Went, Michael J. Mihatsch, and Holger Moch

KIT in Ovarian Carcinoma: Disillusion About a Potential Therapeutic Target
J. Natl. Cancer Inst. 2003 95: 1009; doi:10.1093/jnci/95.13.1009-a [Extract] [Full Text] [PDF]  

Steven Narod and Parviz Ghadirian

RESPONSE: Re: Oral Contraceptives and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
J. Natl. Cancer Inst. 2003 95: 1012; doi:10.1093/jnci/95.13.1012-a [Extract] [Full Text] [PDF]  

IN THIS ISSUE

J. Natl. Cancer Inst. 2003 95: 925; doi:10.1093/jnci/95.13.925-b [Extract] [Full Text] [Japanese Translation]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.